-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Protara Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q1 2013 to Q3 2025.
- Protara Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 42.3M shares, a 89.3% increase year-over-year.
- Protara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 20.6M shares, a 81.7% increase from 2023.
- Protara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 11.3M shares, a 0.64% increase from 2022.
- Protara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11.3M shares, a 0.24% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)